KLCAX
Price
$17.91
Change
+$0.04 (+0.22%)
Updated
Jul 16 closing price
Net Assets
1.25B
RGACX
Price
$80.30
Change
+$0.33 (+0.41%)
Updated
Jul 16 closing price
Net Assets
322.72B
Interact to see
Advertisement

KLCAX vs RGACX

Header iconKLCAX vs RGACX Comparison
Open Charts KLCAX vs RGACXBanner chart's image
Federated Hermes Kaufmann Large Cap A
Price$17.91
Change+$0.04 (+0.22%)
VolumeN/A
Net Assets1.25B
American Funds Growth Fund of Amer R3
Price$80.30
Change+$0.33 (+0.41%)
VolumeN/A
Net Assets322.72B
KLCAX vs RGACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
KLCAX vs. RGACX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KLCAX is a Buy and RGACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 323B vs. KLCAX (1.25B). RGACX pays higher dividends than KLCAX: RGACX (0.07) vs KLCAX (0.00). KLCAX was incepted earlier than RGACX: KLCAX (18 years) vs RGACX (23 years). KLCAX (1.19) is less costly to investors than RGACX (0.94). RGACX is a more actively managed with annual turnover of: 25.00 vs. KLCAX (18.00). RGACX has a lower initial minimum investment than KLCAX: RGACX (250) vs KLCAX (1500). RGACX annual gain was more profitable for investors over the last year : 8.69 vs. KLCAX (-17.38). RGACX return over 5 years is better than : 43.38 vs. KLCAX (-42.69).
KLCAXRGACXKLCAX / RGACX
Total Expense Ratio1.090.94116%
Annual Report Gross Expense Ratio1.190.94127%
Fund Existence18 years23 years-
Gain YTD8.76411.54376%
Front Load6%N/A-
Min. Initial Investment1500250600%
Min. Initial Investment IRAN/AN/A-
Net Assets1.25B323B0%
Annual Yield % from dividends0.000.07-
Returns for 1 year-17.388.69-200%
Returns for 3 years-25.8857.35-45%
Returns for 5 years-42.6943.38-98%
Returns for 10 years-10.4377.95-13%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMMT28.273.91
+16.05%
Summit Therapeutics
AC37.680.38
+1.02%
Associated Capital Group
ELMD18.420.18
+0.99%
Electromed
MTVA0.670.01
+0.93%
MetaVia Inc
CRI30.20-0.56
-1.82%
Carter's